Visualizing Brain Proteinopathies Using [F-18]Flornaptitril-PET in the Prediction of Clinical Progression of Mild Cognitive Impairment With Either Suspected Chronic Traumatic Encephalopathy or Alzheimer's Disease
Clinical trial NCT06254469 · RECRUITING
Trial details
- NCT number
- NCT06254469
- Sponsor
- CereMark Pharma, LLC
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-01
- Primary completion
- 2028-06-30
- Enrollment
- 230
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.